California Public Employees Retirement System’s Harvard Bioscience HBIO Stock Holding History

California Public Employees Retirement System’s Portfolio HBIO Stock Details HBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-2,430	Closed	-$202K	–	1352
2021 Q2	$202K	Sell	2,430 -9,894	-80%	-$700K	﹤0.01%	1469
2021 Q1	$673K	Hold	12,324	–	–	﹤0.01%	2779
2020 Q4	$529K	Hold	12,324	–	–	﹤0.01%	2879
2020 Q3	$371K	Hold	12,324	–	–	﹤0.01%	2961
2020 Q2	$382K	Hold	12,324	–	–	﹤0.01%	2859
2020 Q1	$272K	Sell	12,324 -1,596	-11%	-$43.2K	﹤0.01%	2702
2019 Q4	$425K	Hold	13,920	–	–	﹤0.01%	2807
2019 Q3	$428K	Hold	13,920	–	–	﹤0.01%	2629
2019 Q2	$278K	Hold	13,920	–	–	﹤0.01%	2779
2019 Q1	$600K	Hold	13,920	–	–	﹤0.01%	2499
2018 Q4	$443K	Hold	13,920	–	–	﹤0.01%	2608
2018 Q3	$731K	Hold	13,920	–	–	﹤0.01%	2500
2018 Q2	$745K	Hold	13,920	–	–	﹤0.01%	2480
2018 Q1	$696K	Hold	13,920	–	–	﹤0.01%	2474
2017 Q4	$459K	Hold	13,920	–	–	﹤0.01%	2696
2017 Q3	$522K	Hold	13,920	–	–	﹤0.01%	2640
2017 Q2	$355K	Hold	13,920	–	–	﹤0.01%	2779
2017 Q1	$362K	Hold	13,920	–	–	﹤0.01%	2795
2016 Q4	$425K	Hold	13,920	–	–	﹤0.01%	2758
2016 Q3	$379K	Hold	13,920	–	–	﹤0.01%	2845
2016 Q2	$398K	Hold	13,920	–	–	﹤0.01%	2829
2016 Q1	$420K	Hold	13,920	–	–	﹤0.01%	2803
2015 Q4	$483K	Hold	13,920	–	–	﹤0.01%	2796
2015 Q3	$526K	Hold	13,920	–	–	﹤0.01%	2756
2015 Q2	$793K	Hold	13,920	–	–	﹤0.01%	2647
2015 Q1	$725K	Hold	13,920	–	–	﹤0.01%	2782
2014 Q4	$725K	Hold	13,920	–	–	﹤0.01%	2782
2014 Q3	$569K	Hold	13,920	–	–	﹤0.01%	2889
2014 Q2	$633K	Hold	13,920	–	–	﹤0.01%	2873
2014 Q1	$620K	Hold	13,920	–	–	﹤0.01%	2855
2013 Q4	$700K	Sell	13,920 -4,573	-25%	-$200K	﹤0.01%	2757
2013 Q3	$737K	Hold	18,493	–	–	﹤0.01%	2563
2013 Q2	$663K	Buy	+18,493	New	+$708K	﹤0.01%	2512

Other funds holding HBIO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PCM

Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAIM

Punch & Associates Investment Management Edina, Minnesota $1.73B AUM 27.65% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Harvey Partners Tarrytown, New York $1.26B AUM 64.44% 1-Year Est. Return

California Public Employees Retirement System's HBIO Position: Q3 2021 in Review

California Public Employees Retirement System sold out of Harvard Bioscience (HBIO) in Q3 2021, closing a stake of 2,430 shares — an estimated $202K sold.

California Public Employees Retirement System first reported a position in HBIO in Q2 2013 and held it in 33 quarters. The position peaked at $793K in Q2 2015. 99 funds tracked by Wall St. Rank hold HBIO as of Q3 2021.

California Public Employees Retirement System reported no remaining Harvard Bioscience position as of Q3 2021 after selling out during the quarter.
California Public Employees Retirement System sold 2,430 Harvard Bioscience shares in Q3 2021, an estimated $202K.
California Public Employees Retirement System first reported a position in Harvard Bioscience in Q2 2013 and held it in 33 quarters.
California Public Employees Retirement System's Harvard Bioscience position peaked at $793K in Q2 2015.
99 funds tracked by Wall St. Rank held Harvard Bioscience as of Q3 2021.

Based on California Public Employees Retirement System's 13F filing for Q3 2021, filed 10 Nov 2021.